|
BAZ2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.84780000481666E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.55669999999786E-05 |
| Normal-vs-Stage2 |
9.962800E-03 |
| Normal-vs-Stage3 |
1.08989994807018E-09 |
| Normal-vs-Stage4 |
3.68720054488847E-10 |
| Stage1-vs-Stage2 |
7.882200E-01 |
| Stage1-vs-Stage3 |
8.524900E-03 |
| Stage1-vs-Stage4 |
2.418200E-03 |
| Stage2-vs-Stage3 |
9.159900E-02 |
| Stage2-vs-Stage4 |
2.679900E-02 |
| Stage3-vs-Stage4 |
3.439600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.58670000366601E-08 |
| Normal-vs-AfricanAmerican |
4.441900E-04 |
| Normal-vs-Asian |
9.018600E-01 |
| Caucasian-vs-AfricanAmerican |
6.195000E-01 |
| Caucasian-vs-Asian |
7.097500E-02 |
| AfricanAmerican-vs-Asian |
1.447380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.93449994806616E-09 |
| Normal-vs-Female |
1.958680E-04 |
| Male-vs-Female |
7.744700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.658210E-03 |
| Normal-vs-Age(41-60Yrs) |
8.42330000000446E-05 |
| Normal-vs-Age(61-80Yrs) |
4.16680001613656E-09 |
| Normal-vs-Age(81-100Yrs) |
7.56060000000058E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.691000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.541600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.668000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.495700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.227240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.299200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.453000E-01 |
| Normal-vs-Grade 2 |
5.377900E-04 |
| Normal-vs-Grade 3 |
1.92570404067283E-11 |
| Normal-vs-Grade 4 |
2.80120371343173E-11 |
| Grade 1-vs-Grade 2 |
2.300200E-01 |
| Grade 1-vs-Grade 3 |
2.399900E-03 |
| Grade 1-vs-Grade 4 |
2.951700E-04 |
| Grade 2-vs-Grade 3 |
1.584870E-04 |
| Grade 2-vs-Grade 4 |
1.75567999999293E-05 |
| Grade 3-vs-Grade 4 |
1.960580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.816700E-04 |
| Normal-vs-ccB subtype |
1.70049999637101E-08 |
| ccA subtype-vs-ccB subtype |
1.434260E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97639999999222E-06 |
| Normal-vs-N1 |
8.622400E-04 |
| N0-vs-N1 |
3.740600E-01 |
|
|
